KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Petmed Express (PETS) EBIT (2016 - 2025)

Historic EBIT for Petmed Express (PETS) over the last 17 years, with Q4 2025 value amounting to -$10.5 million.

  • Petmed Express' EBIT fell 222644.44% to -$10.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$59.0 million, marking a year-over-year decrease of 910778.63%. This contributed to the annual value of -$1.5 million for FY2025, which is 8125.46% up from last year.
  • Per Petmed Express' latest filing, its EBIT stood at -$10.5 million for Q4 2025, which was down 222644.44% from -$8.4 million recorded in Q3 2025.
  • Over the past 5 years, Petmed Express' EBIT peaked at $8.4 million during Q1 2021, and registered a low of -$34.1 million during Q2 2025.
  • In the last 5 years, Petmed Express' EBIT had a median value of $461500.0 in 2023 and averaged -$1.1 million.
  • Its EBIT has fluctuated over the past 5 years, first skyrocketed by 30610.9% in 2024, then crashed by 222644.44% in 2025.
  • Petmed Express' EBIT (Quarter) stood at $5.1 million in 2021, then crashed by 114.94% to -$769000.0 in 2022, then crashed by 299.74% to -$3.1 million in 2023, then surged by 85.36% to -$450000.0 in 2024, then crashed by 2226.44% to -$10.5 million in 2025.
  • Its last three reported values are -$10.5 million in Q4 2025, -$8.4 million for Q3 2025, and -$34.1 million during Q2 2025.